{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T22:10:01Z","timestamp":1750716601577,"version":"3.41.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,23]]},"DOI":"10.7759\/cureus.86615","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T21:36:26Z","timestamp":1750714586000},"source":"Crossref","is-referenced-by-count":0,"title":["Hepatic Decompensation Associated With COVID-19 in a Patient With Alcoholic Liver Cirrhosis: A Case Report"],"prefix":"10.7759","author":[{"given":"Martina","family":"Gengo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"World Health Organization. WHO Timeline - COVID-19. (2020). Accessed. February 24, 2025: https:\/\/www.who.int\/news\/item\/27-04-2020-who-timeline---covid-19."},{"key":"ref2","unstructured":"World Health Organization. COVID-19 Epidemiological Update. Edition 169. (2024). Accessed: April 22, 2025: https:\/\/www.who.int\/publications\/m\/item\/covid-19-epidemiological-update-edition-169."},{"key":"ref3","unstructured":"Centers for Disease Control and Prevention. Symptoms of COVID-19. (2025). Accessed. January 27, 2025: https:\/\/www.cdc.gov\/covid\/signs-symptoms\/."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou F","year":"2020","unstructured":"Zhou F, Yu T, Du R, et al.. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020, 395:1054-62. 10.1016\/S0140-6736(20)30566-3","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72\u202f314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu Z","year":"2020","unstructured":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72\u202f314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020, 323:1239-42. 10.1001\/jama.2020.2648","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.5501\/wjv.v12.i1.30","article-title":"COVID-19 in patients with pre-existing chronic liver disease - predictors of outcomes","volume":"12","author":"Walia D","year":"2023","unstructured":"Walia D, Saraya A, Gunjan D. COVID-19 in patients with pre-existing chronic liver disease - predictors of outcomes. World J Virol. 2023, 12:30-43. 10.5501\/wjv.v12.i1.30","journal-title":"World J Virol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1745","article-title":"Impact of COVID-19 in liver disease progression","volume":"5","author":"Martinez MA","year":"2021","unstructured":"Martinez MA, Franco S. Impact of COVID-19 in liver disease progression. Hepatol Commun. 2021, 5:1138-50. 10.1002\/hep4.1745","journal-title":"Hepatol Commun"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.09.024","article-title":"Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study","volume":"74","author":"Marjot T","year":"2021","unstructured":"Marjot T, Moon AM, Cook JA, et al.. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study. J Hepatol. 2021, 74:567-77. 10.1016\/j.jhep.2020.09.024","journal-title":"J Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.04.064","article-title":"Clinical characteristics and outcomes of coronavirus disease 2019 among patients with preexisting liver disease in the United States: a multicenter research network study","volume":"159","author":"Singh S","year":"2020","unstructured":"Singh S, Khan A. Clinical characteristics and outcomes of coronavirus disease 2019 among patients with preexisting liver disease in the United States: a multicenter research network study. Gastroenterology. 2020, 159:768-71.e3. 10.1053\/j.gastro.2020.04.064","journal-title":"Gastroenterology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-021-00426-4","article-title":"COVID-19 and liver disease: mechanistic and clinical perspectives","volume":"18","author":"Marjot T","year":"2021","unstructured":"Marjot T, Webb GJ, Barritt AS 4th, Moon AM, Stamataki Z, Wong VW, Barnes E. COVID-19 and liver disease: mechanistic and clinical perspectives. Nat Rev Gastroenterol Hepatol. 2021, 18:348-64. 10.1038\/s41575-021-00426-4","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2020.00018","article-title":"COVID-19 and liver dysfunction: current insights and emergent therapeutic strategies","volume":"8","author":"Feng G","year":"2020","unstructured":"Feng G, Zheng KI, Yan QQ, et al.. COVID-19 and liver dysfunction: current insights and emergent therapeutic strategies. J Clin Transl Hepatol. 2020, 8:18-24. 10.14218\/JCTH.2020.00018","journal-title":"J Clin Transl Hepatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajg.2020.03.002","article-title":"Hepatic and gastrointestinal involvement in coronavirus disease 2019 (COVID-19): What do we know till now?","volume":"21","author":"Musa S","year":"2020","unstructured":"Musa S. Hepatic and gastrointestinal involvement in coronavirus disease 2019 (COVID-19): What do we know till now?. Arab J Gastroenterol. 2020, 21:3-8. 10.1016\/j.ajg.2020.03.002","journal-title":"Arab J Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v28.i39.5666","article-title":"COVID-19 and hepatorenal syndrome","volume":"28","author":"Wu HH","year":"2022","unstructured":"Wu HH, Athwal VS, Kalra PA, Chinnadurai R. COVID-19 and hepatorenal syndrome. World J Gastroenterol. 2022, 28:5666-78. 10.3748\/wjg.v28.i39.5666","journal-title":"World J Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/lt.25981","article-title":"Cirrhosis is associated with high mortality and readmissions over 90 days regardless of COVID-19: a multicenter cohort","volume":"27","author":"Bajaj JS","year":"2021","unstructured":"Bajaj JS, Garcia-Tsao G, Wong F, et al.. Cirrhosis is associated with high mortality and readmissions over 90 days regardless of COVID-19: a multicenter cohort. Liver Transpl. 2021, 27:1343-7. 10.1002\/lt.25981","journal-title":"Liver Transpl"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3138\/canlivj-2020-0007","article-title":"Practical management of esophageal varices in the context of SARS-CoV-2 (COVID-19): the Alberta protocol","volume":"3","author":"Congly SE","year":"2020","unstructured":"Congly SE, Sadler MD, Abraldes JG, Tandon P, Lee SS, Burak KW. Practical management of esophageal varices in the context of SARS-CoV-2 (COVID-19): the Alberta protocol. Can Liver J. 2020, 3:300-3. 10.3138\/canlivj-2020-0007","journal-title":"Can Liver J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.06.001","article-title":"High rates of 30-day mortality in patients with cirrhosis and COVID-19","volume":"73","author":"Iavarone M","year":"2020","unstructured":"Iavarone M, D'Ambrosio R, Soria A, et al.. High rates of 30-day mortality in patients with cirrhosis and COVID-19. J Hepatol. 2020, 73:1063-71. 10.1016\/j.jhep.2020.06.001","journal-title":"J Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-2803.201800000-71","article-title":"Recommendations of the Brazilian Society of Hepatology for the management of acute kidney injury in patients with cirrhosis","volume":"55","author":"Terra C","year":"2018","unstructured":"Terra C, Mattos \u00c2Z, Pereira G, et al.. Recommendations of the Brazilian Society of Hepatology for the management of acute kidney injury in patients with cirrhosis. Arq Gastroenterol. 2018, 55:314-20. 10.1590\/S0004-2803.201800000-71","journal-title":"Arq Gastroenterol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2020-BTSabstracts.323","article-title":"P178 COVID-19 post-discharge mortality rate in a London district general hospital","volume":"76","author":"Navvas J","year":"2021","unstructured":"Navvas J, Varghese R, Selvakannan B, et al.. P178 COVID-19 post-discharge mortality rate in a London district general hospital. Thorax. 2021, 76:186-7. 10.1136\/thorax-2020-BTSabstracts.323","journal-title":"Thorax"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/370950-hepatic-decompensation-associated-with-covid-19-in-a-patient-with-alcoholic-liver-cirrhosis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T21:36:28Z","timestamp":1750714588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/370950-hepatic-decompensation-associated-with-covid-19-in-a-patient-with-alcoholic-liver-cirrhosis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.86615","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,23]]}}}